Royalty Pharma (RPRX) Free Cash Flow Growth (3y) (2022 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Free Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | -4.45% |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | 45.89% |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | 33.09% |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | - |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | 63.46% |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | -62.02% |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn | 18.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.45% |
| Mar 31, 2026 | -14.95% |
| Dec 31, 2025 | -33.63% |
| Sep 30, 2025 | 30.66% |
| Jun 30, 2025 | -3.19% |
| Mar 31, 2025 | 8.94% |
| Dec 31, 2024 | -8.21% |
| Sep 30, 2024 | 17.24% |
| Jun 30, 2024 | -30.07% |
| Mar 31, 2024 | 192.88% |
| Dec 31, 2023 | 1.39% |
| Sep 30, 2023 | 34.20% |
| Jun 30, 2023 | 242.08% |
| Mar 31, 2023 | 5.14% |
| Dec 31, 2022 | 201.53% |
| Sep 30, 2022 | -58.24% |